DOI:
10.1055/s-00000054
Pharmacopsychiatry
LinksClose Window
References
Ravenstijn P, Remmerie B, Savitz A. et al.
Pharmacokinetics, safety, and tolerability of paliperidone palmitate 3-month formulation in patients with schizophrenia: A phase 1, single-dose, randomized, open-label study.
J Clin Pharmacol 2016;
56: 330-339
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.